Benzinga•2026-04-20
QuidelOrtho Completes Acquisition Of LEX Diagnostics For Cash Consideration Of ~$100M; Co. Expects To Initiate U.S. Commercial Launch Of LEX VELO System Later This YearQDEL — QuidelOrtho Corp
NASDAQ · Health Care · Health Care
$11.90-58.68%Market cap1.09B
- Latest Close
- $11.9
- 30-Day Move
- -58.7%
- Market Cap
- $1.1B
- Shares Outstanding
- 68,080,000
- P/B Ratio
- 1.04
- ROE
- -58.9%
NASDAQ:QDELHealth Care / Health CareDelayed public snapshot
QuidelOrtho Corp
A read-only Alphactor snapshot forQuidelOrtho Corp. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-22
Topline snapshot
Latest Close
$11.9
30-Day Move
-58.7%
Market Cap
$1.1B
Shares Outstanding
68,080,000
P/B Ratio
1.04
ROE
-58.9%
Not investment advice. Signals and scores shown here are model outputs derived from historical data, not recommendations. Past performance does not guarantee future results. Do your own research before trading. Full disclaimer
Chart snapshot
$11.90
-58.7%last 90 delayed daily bars
Market cap$1.1B
90D High
$35.58
90D Low
$11.61
Avg Volume
1,585,117
What stands out
Gross margin is running at 46.7%, which gives a quick read on operating quality before you open the full model.
Net margin is -41.5%, useful for comparing QDEL against peers in Health Care.
QDEL is down 58.7% over the last 30 trading days shown on this page.
Latest operating income is $-37M, which helps anchor the headline ratios with an actual earnings figure.
Research snapshot
Composite Fair Value
$161.38
Rule of 40
-4.9%
Dark Pool Short %
51.1%
Fundamentals snapshot
Latest Close
$11.9
30-Day Move
-58.7%
Market Cap
$1.1B
Shares Outstanding
68,080,000
P/B Ratio
1.04
ROE
-58.9%
ROA
-19.6%
Gross Margin
46.7%
Operating Margin
-33.9%
Net Margin
-41.5%
Debt / Equity
1.38
Current Ratio
1.5
Latest Revenue
$724M
Financial statement snapshot
Revenue
$724M
Gross Profit
$320M
Operating Income
$-37M
Net Income
$-131M
Gross Margin
4667.0%
Net Margin
-4145.0%
Current Ratio
1.50
Debt / Equity
1.38
Valuation snapshot
Fair Value
$161.38
Upside / Downside
+1256.1%
Signal
Undervalued
Implied Growth
16.4%
EV/Rev
$161.38
Growth Assumption
-5.8%
Discount Rate
10.1%
Terminal Growth
2.0%
Base FCF
$105M
Valuation spread
Current Price
$11.90
Composite Fair Value
$161.38
EV/Rev
$161.38
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Moderate growth priced in
Quality snapshot
Altman Z
0.53
Distress
Piotroski
6
Moderate (4-6)
Cash Conversion
-0.09x
Rule of 40
-4.9%
Concerning
Annual financial history
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $3.3B | $983M | $549M | $744M |
| 2023-12-31 | $3.0B | $257M | $-10M | $71M |
| 2024-12-31 | $2.8B | $46M | $-2.1B | $-112M |
| 2025-12-31 | $2.7B | $55M | $-1.1B | $-83M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
News snapshot
Finnhub•2026-04-20
QuidelOrtho Corporation Completes Acquisition of LEX DiagnosticsSeekingAlpha•2026-04-18
QuidelOrtho Looks Mispriced If 2026's FCF Turnaround MaterializesChartMill•2026-04-16
Keep an eye on the top gainers and losers in Thursday's session.ChartMill•2026-04-16
What's going on in today's sessionAfter signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Insider activity snapshot
Buy Value
$1M
Sell Value
$111,965.48
Buys
9
Sells
1
Buy Value
$1M
Sell Value
$111,965.48
Buy/Sell Ratio
9.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
Recent insider transactions
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-15 | SISITSKY NATHANIEL | A | 73,434 | $0.00 |
| 2026-04-15 | SISITSKY NATHANIEL | A | 73,435 | $0.00 |
| 2026-03-28 | Busky Joseph M. | M | 4,925 | $0.00 |
| 2026-03-28 | Busky Joseph M. | F | 1,519 | $14.78 |
| 2026-03-28 | Busky Joseph M. | A | 4,925 | $0.00 |
| 2026-02-13 | Blaser Brian J. | Buy | 10,540 | $23.59 |
| 2026-02-13 | Busky Joseph M. | Buy | 3,370 | $23.66 |
| 2026-02-13 | Strobeck Matthew | Buy | 10,000 | $23.96 |
ETF holders snapshot
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 4,126,087 | 0.06% | 2026-02-28 |
| AIM Sector Funds (Invesco Sector Funds)-INVESCO SMALL CAP VALUE FUND | 3,179,348 | 0.05% | 2026-01-31 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 2,811,300 | 0.04% | 2025-12-31 |
| American Century ETF Trust-Avantis U.S. Small Cap Value ETF | 2,410,994 | 0.04% | 2026-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2,155,951 | 0.03% | 2025-12-31 |
| Fidelity Securities Fund-Fidelity Small Cap Value Fund | 1,729,427 | 0.03% | 2026-01-31 |
| Fidelity Capital Trust-Fidelity Value Fund | 1,730,300 | 0.03% | 2026-02-28 |
| iShares Trust-iShares Russell 2000 ETF | 1,654,947 | 0.02% | 2026-02-28 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Institutional holders snapshot
Vanguard Group
Filed 2025-05-09
$236M
-1.0%
BlackRock
Filed 2024-05-10
$233M
--
FMR LLC (Fidelity)
Filed 2026-02-17
$155M
+20.6%
Invesco
Filed 2026-02-19
$99M
+19.4%
Goldman Sachs
Filed 2026-02-10
$50M
+101.2%
Geode Capital Management
Filed 2025-11-12
$49M
-0.9%
Dark-pool activity snapshot
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Healthcare Investing: Pharma, Biotech, and the FDA Calendar
A framework for navigating healthcare stocks across pharma, biotech, and medical devices, with emphasis on regulatory catalysts and pipeline valuation.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.